COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHODS FOR USE IN TREATING METABOLIC DISORDERS
The present invention is directed to novel compounds of formula (I) and their use in treating metabolic diseases.
-
Page/Page column 207
(2010/06/22)
Asymmetric hydrogenation of itaconic acid and enol acetate derivatives with the Rh-TangPhos catalyst
(Matrix presented) The Rh-TangPhos catalyst has been used for asymmetric hydrogenation of itaconic acid and enol acetate derivatives. A variety of chiral 2-substituted succinic acids and chiral acetates have been obtained in excellent ee values (up to 99% ee).
Tang, Wenjun,Liu, Duan,Zhang, Xumu
p. 205 - 207
(2007/10/03)
Practical access to 2-alkylsuccinates through asymmetric catalytic hydrogenation of Stobbe-derived itaconates
Enantiomerically pure 2-alkylsuccinates are obtained on a 500-g scale after hydrogenation with the cationic rhodium complexes with tetraalkyl-substituted 1,2-bis(phospholanyl)ethane or -benzene ligands [R'-DuPHOS; Eq. (a)]. The catalysts allow smooth hydr
Burk, Mark J.,Bienewald, Frank,Harris, Michael,Zanotti-Gerosa, Antonio
p. 1931 - 1933
(2007/10/03)
More Articles about upstream products of 119807-84-0